A clinical trial to investigate DTX-401 for the treatment of glycogen storage disease type Ia

Trial Profile

A clinical trial to investigate DTX-401 for the treatment of glycogen storage disease type Ia

Planning
Phase of Trial: Phase I

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs DTX 401 (Primary)
  • Indications Glycogen storage disease type I
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jun 2017 According to a Dimension Therapeutics media release, the company anticipates IND filing early 2018 and expect initial clinical data from the trial mid-2018.
    • 29 Mar 2016 New trial record
    • 24 Mar 2016 According to a Dimension Therapeutics media release, an IND filing is anticipated in 2H 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top